This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: When will a patient who has received ibritumomab tiuxetan with yttrium-90 (IT-Y90) reach the ... (Read 45 times)

sheilaspns

  • Hero Member
  • *****
  • Posts: 567
on: Jul 23, 2018
When will a patient who has received ibritumomab tiuxetan with yttrium-90 (IT-Y90) reach the hematologic nadir?
 
  1. During days 5-10
  2. 10-14 days after infusion
  3. In 30 days
  4. In 7-9 weeks

Question 2

To help minimize side effects in a cancer patient receiving interferon-alfa therapy, the nurse should:
 
  1. start oxygen.
  2. lower the ambient temperature.
  3. provide antiemetics.
  4. administer acetaminophen.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meow1234

  • Sr. Member
  • ****
  • Posts: 333
Reply #1 on: Jul 23, 2018
Answer to Question 1

Correct Answer: 4

Answer to Question 2

Correct Answer: 4


sheilaspns

  • Member
  • Posts: 567
Reply 2 on: Jul 23, 2018
Wow, this really help

okolip

  • Member
  • Posts: 362
Reply 3 on: Yesterday
:D TYSM

« previous next »
 

Did you know?

Although the Roman numeral for the number 4 has always been taught to have been "IV," according to historians, the ancient Romans probably used "IIII" most of the time. This is partially backed up by the fact that early grandfather clocks displayed IIII for the number 4 instead of IV. Early clockmakers apparently thought that the IIII balanced out the VIII (used for the number 8) on the clock face and that it just looked better.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Patient Position for Posterior Percussion Patient Position for Posterior Percussion
Symptoms of a patient in shock. Symptoms of a patient in shock.
Cirrhosis. Cirrhosis is characterized by a chronic deterioration of the liver, replacing healthy cel Cirrhosis. Cirrhosis is characterized by a chronic deterioration of the liver, replacing healthy cel
PET Scans of a Patient with Parkinsonian Symptoms PET Scans of a Patient with Parkinsonian Symptoms
Medical assistants can quickly pull up a patient record when a phone call is received. Medical assistants can quickly pull up a patient record when a phone call is received.
Video: Exercise and cardiac output & Definition of stroke volume

For a complete list of videos, visit our video library